NanoViricides

Quarterly Financials

Values in thousands 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-191
-195
-195
-190
EBITDA
-2,249
-1,831
-2,931
-2,165
EBIT
-2,440
-2,027
-3,126
-2,355
Net Income
-2,216
-2,027
-3,126
-2,355
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,990
-2,190
-2,641
-1,579
Cash
2,542
3,958
3,866
4,797
Basic Shares
16,026
14,572
13,715
11,871

Annual Financials

Values in thousands 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-759
-747
-723
-704
EBITDA
-7,485
-7,840
-7,378
-8,032
EBIT
-8,244
-8,587
-8,101
-8,736
Net Income
-8,294
-8,588
-8,100
-8,822
Net Change In Cash
0
0
0
0
Free Cash Flow
-6,472
-5,821
-6,215
-8,452
Cash
4,797
8,149
14,066
20,516
Basic Shares
11,871
11,626
11,534
10,900

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0
2025-03-31
-$0.13
2024-12-31
-$0.13